225 related articles for article (PubMed ID: 24462873)
1. Effect of adiponectin on cardiac β-catenin signaling pathway under angiotensin II infusion.
Fujishima Y; Maeda N; Matsuda K; Komura N; Hirata A; Mori T; Sekimoto R; Tsushima Y; Nishizawa H; Funahashi T; Shimomura I
Biochem Biophys Res Commun; 2014 Feb; 444(2):224-9. PubMed ID: 24462873
[TBL] [Abstract][Full Text] [Related]
2. DKK3 overexpression attenuates cardiac hypertrophy and fibrosis in an angiotensin-perfused animal model by regulating the ADAM17/ACE2 and GSK-3β/β-catenin pathways.
Zhai CG; Xu YY; Tie YY; Zhang Y; Chen WQ; Ji XP; Mao Y; Qiao L; Cheng J; Xu QB; Zhang C
J Mol Cell Cardiol; 2018 Jan; 114():243-252. PubMed ID: 29196099
[TBL] [Abstract][Full Text] [Related]
3. Adiponectin modulates the glycogen synthase kinase-3beta/beta-catenin signaling pathway and attenuates mammary tumorigenesis of MDA-MB-231 cells in nude mice.
Wang Y; Lam JB; Lam KS; Liu J; Lam MC; Hoo RL; Wu D; Cooper GJ; Xu A
Cancer Res; 2006 Dec; 66(23):11462-70. PubMed ID: 17145894
[TBL] [Abstract][Full Text] [Related]
4. Evidence for the importance of adiponectin in the cardioprotective effects of pioglitazone.
Li P; Shibata R; Unno K; Shimano M; Furukawa M; Ohashi T; Cheng X; Nagata K; Ouchi N; Murohara T
Hypertension; 2010 Jan; 55(1):69-75. PubMed ID: 19933924
[TBL] [Abstract][Full Text] [Related]
5. Cardiac-specific Traf2 overexpression enhances cardiac hypertrophy through activating AKT/GSK3β signaling.
Huang Y; Wu D; Zhang X; Jiang M; Hu C; Lin J; Tang J; Wu L
Gene; 2014 Feb; 536(2):225-31. PubMed ID: 24378234
[TBL] [Abstract][Full Text] [Related]
6. Dioscin ameliorates cardiac hypertrophy through inhibition of the MAPK and Akt/GSK3β/mTOR pathways.
Chen L; Li Q; Lei L; Li T
Life Sci; 2018 Sep; 209():420-429. PubMed ID: 30125581
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II increases fibronectin and collagen I through the β-catenin-dependent signaling in mouse collecting duct cells.
Cuevas CA; Gonzalez AA; Inestrosa NC; Vio CP; Prieto MC
Am J Physiol Renal Physiol; 2015 Feb; 308(4):F358-65. PubMed ID: 25411386
[TBL] [Abstract][Full Text] [Related]
8. FKBP12.6 protects heart from AngII-induced hypertrophy through inhibiting Ca
Xiao YF; Zeng ZX; Guan XH; Wang LF; Wang CJ; Shi H; Shou W; Deng KY; Xin HB
J Cell Mol Med; 2018 Jul; 22(7):3638-3651. PubMed ID: 29682889
[TBL] [Abstract][Full Text] [Related]
9. Interruption of Wnt signaling attenuates the onset of pressure overload-induced cardiac hypertrophy.
van de Schans VA; van den Borne SW; Strzelecka AE; Janssen BJ; van der Velden JL; Langen RC; Wynshaw-Boris A; Smits JF; Blankesteijn WM
Hypertension; 2007 Mar; 49(3):473-80. PubMed ID: 17210832
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin type 1 receptor mediates thyroid hormone-induced cardiomyocyte hypertrophy through the Akt/GSK-3beta/mTOR signaling pathway.
Diniz GP; Carneiro-Ramos MS; Barreto-Chaves ML
Basic Res Cardiol; 2009 Nov; 104(6):653-67. PubMed ID: 19588183
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Rho-kinase by fasudil attenuated angiotensin II-induced cardiac hypertrophy in apolipoprotein E deficient mice.
Wang YX; da Cunha V; Martin-McNulty B; Vincelette J; Li W; Choy DF; Halks-Miller M; Mahmoudi M; Schroeder M; Johns A; Light DR; Dole WP
Eur J Pharmacol; 2005 Apr; 512(2-3):215-22. PubMed ID: 15840407
[TBL] [Abstract][Full Text] [Related]
12. C-C Motif Chemokine Receptor 9 Exacerbates Pressure Overload-Induced Cardiac Hypertrophy and Dysfunction.
Xu Z; Mei F; Liu H; Sun C; Zheng Z
J Am Heart Assoc; 2016 May; 5(5):. PubMed ID: 27146447
[TBL] [Abstract][Full Text] [Related]
13. Adiponectin is required for cardiac MEF2 activation during pressure overload induced hypertrophy.
Dadson K; Turdi S; Hashemi S; Zhao J; Polidovitch N; Beca S; Backx PH; McDermott JC; Sweeney G
J Mol Cell Cardiol; 2015 Sep; 86():102-9. PubMed ID: 26196305
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of protein phosphatase 2A in a murine model of chronic myocardial infarction leads to increased adverse remodeling but restores the regulation of β-catenin by glycogen synthase kinase 3β.
Hoehn M; Zhang Y; Xu J; Gergs U; Boknik P; Werdan K; Neumann J; Ebelt H
Int J Cardiol; 2015 Mar; 183():39-46. PubMed ID: 25662052
[TBL] [Abstract][Full Text] [Related]
15. Lysosomal cysteine peptidase cathepsin L protects against cardiac hypertrophy through blocking AKT/GSK3beta signaling.
Tang Q; Cai J; Shen D; Bian Z; Yan L; Wang YX; Lan J; Zhuang GQ; Ma WZ; Wang W
J Mol Med (Berl); 2009 Mar; 87(3):249-60. PubMed ID: 19096818
[TBL] [Abstract][Full Text] [Related]
16. Adiponectin protects against angiotensin II-induced cardiac fibrosis through activation of PPAR-alpha.
Fujita K; Maeda N; Sonoda M; Ohashi K; Hibuse T; Nishizawa H; Nishida M; Hiuge A; Kurata A; Kihara S; Shimomura I; Funahashi T
Arterioscler Thromb Vasc Biol; 2008 May; 28(5):863-70. PubMed ID: 18309113
[TBL] [Abstract][Full Text] [Related]
17. Depletion of mammalian target of rapamycin (mTOR) via siRNA mediated knockdown leads to stabilization of beta-catenin and elicits distinct features of cardiomyocyte hypertrophy.
Hagenmueller M; Malekar P; Fieger C; Weiss CS; Buss SJ; Wolf D; Katus HA; Hardt SE
FEBS Lett; 2010 Jan; 584(1):74-80. PubMed ID: 19883644
[TBL] [Abstract][Full Text] [Related]
18. Baicalein attenuates angiotensin II-induced cardiac remodeling via inhibition of AKT/mTOR, ERK1/2, NF-κB, and calcineurin signaling pathways in mice.
Wang AW; Song L; Miao J; Wang HX; Tian C; Jiang X; Han QY; Yu L; Liu Y; Du J; Xia YL; Li HH
Am J Hypertens; 2015 Apr; 28(4):518-26. PubMed ID: 25362112
[TBL] [Abstract][Full Text] [Related]
19. OBG-like ATPase 1 inhibition attenuates angiotensin II-induced hypertrophic response in human ventricular myocytes via GSK-3beta/beta-catenin signalling.
Narasimhan G; Henderson J; Luong HT; Rajasekaran NS; Qin G; Zhang J; Krishnamurthy P
Clin Exp Pharmacol Physiol; 2019 Aug; 46(8):743-751. PubMed ID: 31063653
[TBL] [Abstract][Full Text] [Related]
20. NADPH oxidase 4 induces cardiac fibrosis and hypertrophy through activating Akt/mTOR and NFκB signaling pathways.
Zhao QD; Viswanadhapalli S; Williams P; Shi Q; Tan C; Yi X; Bhandari B; Abboud HE
Circulation; 2015 Feb; 131(7):643-55. PubMed ID: 25589557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]